Esperion Therapeutics
ESPR
#6721
Rank
S$0.66 B
Marketcap
$3.39
Share price
2.02%
Change (1 day)
102.36%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.93 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are S$0.93 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.87 B13.86%
2022-12-31S$0.76 B-2.01%
2021-12-31S$0.78 B31.56%
2020-12-31S$0.59 B126.73%
2019-12-31S$0.26 B198.35%
2018-12-31S$87.88 M98.26%
2017-12-31S$44.33 M84.39%
2016-12-31S$24.04 M104.45%
2015-12-31S$11.75 M-8.46%
2014-12-31S$12.84 M141.24%
2013-12-31S$5.32 M-82.37%
2012-12-31S$30.2 M183.2%
2011-12-31S$10.66 M
2002-12-31S$21.97 M0.24%
2001-12-31S$21.92 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$1.59 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.93 B 106.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$170.76 B 18,121.23%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.91 B 1,065.19%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.81 B-12.75%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.17 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA